Document is current
Any future updates will be listed below
-
Authors
Nilsson, Staffan
Gabro, Fade
Stertman, Erik
Bernfort, Lars
Fredrikson, Mats
Henriksson, Pontus
Johansson, Peter
Kastbom, Lisa
Kärner Köhler, Anita
Lööf, Johan
Mourad, Ghassan
Olsson, Eva
Valladares, Carlos
Östgren, Carl Johan
Sederholm Lawesson, Sofia
Engvall, Jan
Iredahl, Fredrik https://orcid.org/0000-0002-4245-7565
-
Funding
Funding for this research was provided by:
Vetenskapsrådet (2023-05738)
ALF Region Östergötland (RÖ-994046, RÖ-999705)
Linköping University
- License Information
-
More Information
Article History
Received: 19 September 2024
Accepted: 3 June 2025
First Online: 21 June 2025
Declarations
:
: Participants’ consent form is provided on request.
: SLL reported speaker fees from Bayer, Pfizer, Novartis, Astra Zeneca, and Boehringer and Ingelheim, and advisory board participation for Novartis and FI from Novo Nordisk and Boehringer and Ingelheim. All other authors have no competing interests to declare. Region Östergötland is the employer of SN, ES, JE, LK, JL, EO, CJÖ, SLL, JE, and FI.
